Mr Richard S Kollender

KANDO id: 12085

Bio

Joined Quaker BioVentures in 2003 and promoted to Partner in 2005. Previously: Held positions in sales, marketing and worldwide business development at GlaxoSmithKline. Also served as investment manager at S.R. One where he evaluated potential investment opportunities, performed due diligence, structured and negotiated investments and worked with management teams to execute their strategies following investment. Began his career as a CPA with KPMG Peat Marwick with an emphasis on the healthcare and emerging businesses sectors. Nupathe, Precision Therapeutics, Rapid Micro Biosystems, TargetRx, and Transave. BA from Franklin and Marshall College, MBA and Health Administration & Policy degrees with Honors from the University of Chicago.

Education